In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 214894-89-0, name is 5-(Bromomethyl)-2,3-dihydro-1,4-benzodioxine, introducing its new discovery. Formula: C9H9BrO2
BETA-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
Provided are novel compounds having an inhibitory activity against production or secretion of beta-amyloid protein. They embrace compounds represented by the following formula (1): and capable of being replaced with a variety of substituents; and salts thereof, and solvates of any one of them.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 214894-89-0, and how the biochemistry of the body works.Formula: C9H9BrO2
Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem